Diagnostic criteria for 292.89 Hallucinogen Intoxication
(cautionary statement)
A. Recent use of a hallucinogen.
B. Clinically significant maladaptive behavioral or psychological changes (e.g., marked
anxiety or depression, ideas of
reference, fear of losing one's mind, paranoid
ideation, impaired judgment, or impaired social or occupational functioning) that developed during, or shortly after, hallucinogen use.
C. Perceptual changes occurring in a state of full wakefulness and alertness (e.g., subjective intensification of perceptions,
depersonalization, derealization,
illusions, hallucinations,
synesthesias) that developed during, or shortly after, hallucinogen use.
D. Two (or more) of the following signs, developing during, or shortly after, hallucinogen use:
(1) pupillary dilation
(2) tachycardia
(3) sweating
(4) palpitations
(5) blurring of vision
(6) tremors
(7) incoordination
E. The symptoms are not due to a general medical condition and are not better accounted for by another
mental disorder.
Reprinted with permission from the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision. Copyright 2000 American Psychiatric Association
|
